ADVFN ADVFN

Hot Features

Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Biomarin Phar Dl 001

Biomarin Phar Dl 001 (0HNC)

89.36
0.00
( 0.00% )
更新日時: 09:00:00

Biomarin Phar Dl 001 (0HNC) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
89.36
( - )
買値
89.36
売値
89.36
出来高
0.00
0.00 日の範囲 0.00
89.36 52 週間の範囲 89.36
時価総額
前日終値
89.36
始値
-
時刻
(O)
最終取引時間
-
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 2,080,162
発行済株式数
193,284,438
配当利回り
PER
40.97
1 株当たり利益 (EPS)
1.4
歳入
3.24B
純利益
268.74M

Biomarin Phar Dl 001 について

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company’s products i... BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company’s products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic peptide (CNP) for the treatment of achondroplasia; NAGLAZYME, a recombinant form of N- acetylgalactosamine 4-sulfatase for patients with MPS VI; and PALYNZIQ, a PEGylated recombinant phenylalanine (Phe) ammonia lyase enzyme delivered through subcutaneous injection to reduce blood Phe concentrations. It also develops BRINEURA, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; ALDURAZYME, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase; and KUVAN, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria, an inherited metabolic disease. The company’s products under development include BMN 333, a longer-acting CNP for the treatment of multiple growth disorders, such as achondroplasia and hypochondroplasia; and BMN 351, an oligonucleotide for the treatment of duchenne muscular dystrophy. It serves specialty pharmacies, hospitals, non-U.S. government agencies, distributors, and pharmaceutical wholesalers. The company has license and collaboration agreements with and Ares Trading S.A. The company was incorporated in 1996 and is based in San Rafael, California. 詳細を表示

セクター
-
業界
-
ウェブサイト
本社
San Rafael, United States
設立
1996
Biomarin Phar Dl 001 is listed in the sector of the ロンドン証券取引所 with ticker 0HNC. The last closing price for Biomarin Phar Dl 001 was US$89.36. Over the last year, Biomarin Phar Dl 001 shares have traded in a share price range of US$ 89.36 to US$ 89.36.

Biomarin Phar Dl 001 currently has 193,284,438 shares in issue. The market capitalisation of Biomarin Phar Dl 001 is US$17.27 billion. Biomarin Phar Dl 001 has a price to earnings ratio (PE ratio) of 40.97.

0HNC 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DE
40000000DE
120000000DE
260089.3689.3689.36135289.36DE
520089.3689.3689.36124689.36DE
1560089.3689.3689.36236789.36DE
2600089.3689.3689.36338989.36DE

0HNC - Frequently Asked Questions (FAQ)

What is the current Biomarin Phar Dl 001 share price?
The current share price of Biomarin Phar Dl 001 is US$ 89.36
How many Biomarin Phar Dl 001 shares are in issue?
Biomarin Phar Dl 001 has 193,284,438 shares in issue
What is the market cap of Biomarin Phar Dl 001?
The market capitalisation of Biomarin Phar Dl 001 is USD 17.27B
What is the 1 year trading range for Biomarin Phar Dl 001 share price?
Biomarin Phar Dl 001 has traded in the range of US$ 89.36 to US$ 89.36 during the past year
What is the PE ratio of Biomarin Phar Dl 001?
The price to earnings ratio of Biomarin Phar Dl 001 is 40.97
What is the cash to sales ratio of Biomarin Phar Dl 001?
The cash to sales ratio of Biomarin Phar Dl 001 is 3.41
What is the registered address of Biomarin Phar Dl 001?
The registered address for Biomarin Phar Dl 001 is 770 Lindaro Street, San Rafael, California, 94901
What is the Biomarin Phar Dl 001 website address?
The website address for Biomarin Phar Dl 001 is www.biomarin.com

0HNC 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock